AstraZeneca and Daiichi Sankyo have submitted a new Biologics License Application (BLA) for accelerated approval in the US ...
Japan's nuclear watchdog on Wednesday formally disqualified a reactor in the country's north-central region from restarting, ...
This is the first reactor barred in Japan under stricter safety protocols adopted after the Fukushima disaster.